Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Work In Process (2019 - 2025)

Historic Work In Process for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $7.3 million.

  • Outset Medical's Work In Process fell 2664.19% to $7.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.3 million, marking a year-over-year decrease of 2664.19%. This contributed to the annual value of $7.3 million for FY2025, which is 2664.19% down from last year.
  • As of Q4 2025, Outset Medical's Work In Process stood at $7.3 million, which was down 2664.19% from $7.5 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Work In Process registered a high of $13.9 million during Q3 2024, and its lowest value of $6.1 million during Q4 2021.
  • Its 5-year average for Work In Process is $9.4 million, with a median of $9.3 million in 2022.
  • Its Work In Process has fluctuated over the past 5 years, first surged by 16381.44% in 2021, then plummeted by 4624.4% in 2025.
  • Quarter analysis of 5 years shows Outset Medical's Work In Process stood at $6.1 million in 2021, then skyrocketed by 50.08% to $9.1 million in 2022, then fell by 3.94% to $8.7 million in 2023, then rose by 14.26% to $10.0 million in 2024, then dropped by 26.64% to $7.3 million in 2025.
  • Its last three reported values are $7.3 million in Q4 2025, $7.5 million for Q3 2025, and $7.6 million during Q2 2025.